IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii

European Journal of Immunology

Volumn 40, Issue 2, 2010, Pages 426-436

  Jones, Leigh A ^a   Roberts, Fiona ^b   Nickdel, Mohammad B ^a   Brombacher, Frank ^c   McKenzie, Andrew N J ^d   Henriquez, Fiona L ^a   Alexander, James ^a   Roberts, Craig W ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Encephalitis; IL 33; IL 33 receptor; Th1 Th2; Toxoplasma

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; UPREGULATION;

ANIMALS; BODY WEIGHT; BRAIN; ENCEPHALITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75149148187     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939705     Document Type: Article

References (52)

1. Tominaga, S., Jenkins, N. A., Gilbert, D. J., Copeland, N. G. and Tetsuka, T., Molecular cloning of the murine ST2 gene: characterization and chromosomal mapping. Biochim. Biophys. Acta 1991. 1090: 1-8.
2. Bergers, G., Reikerstorfer, A., Braselmann, S., Graninger, P. and Busslinger, M., Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 1994. 13: 1176-1188.
3. Carter, R.W., Sweet, M. J., Xu, D., Klemenz, R., Liew, F. Y. and Chan,W. L., Regulation of ST2L expression on T helper (Th) type 2 cells. Eur. J. Immunol. 2001. 31: 2979-2985.
4. Kumar, R. K. and Foster, P. S., ST2: marker, activator and regulator of Th2 immunity? Clin. Exp. Allergy 2002. 32: 1394-1396.
5. Moritz, D. R., Rodewald, H. R., Gheyselinck, J. and Klemenz, R., The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 1998. 161: 4866-4874.
6. Oshikawa, K., Yanagisawa, K., Tominaga, S. and Sugiyama, Y., ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem. Biophys. Res. Commun. 2002. 299: 18-24.
7. Bourgeois, E., Van, L. P., Samson, M., Diem, S., Barra, A., Roga, S., Gombert, J-M. et al., The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. Eur. J. Immunol. 2009. 39: 1046-1055.
8. Kropf, P., Hearth, S., Klemenz, R. and Muller, I., Signalling through the T1/ ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection. Infect. Immun. 2003. 71: 1961-1971.
9. Meisel, C., Bonhagen, K., Löhning, M., Coyle, A. J., Gutierrez-Ramos, J-C., Radbruch, A. and Kamradt, T., Regulation and function of T1/ST2 expression on CD4+T cells: Induction of type 2 cytokine production by T1/ST2 cross-linking. J. Immunol. 2001. 166: 3143-3150.
10. Liew, F.Y., Liu, H. and Xu, D., A novel negative regulator for IL-1 receptor and toll-like receptor 4. Immunol. Lett. 2005. 96: 27-31.
11. Sweet, M. J., Leung, B. P., Kang, D., Sogaard, M., Schulz, K., Trajkovic, V., Campbell, C. C. et al., A novel pathway regulating lipopolysaccharideinduced shock by ST2/T1 inhibition of toll-like receptor 4 expression. J. Immunol. 2001. 166: 6633-6639.
12. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type-2 associated cytokines. Immunity 2005. 23: 479-490.
13. Chackerian, A. A, Oldham, E. R., Murphy, E. E, Schmitz, J., Pflanz, S. and Kastelain, R. A., IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 2007. 179: 2551-2555.
14. Lieberman, L. A. and Hunter, C. A. The role of cytokines and their signalling pathways in the regulation of immunity to Toxoplasma gondii. Int. Rev. Immunol. 2002. 21: 373-403.
15. Townsend, M. J., Fallon, P. G, Matthews, D. J., Jolin, H. E and McKenzie, A. N. J., T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 2000. 191: 1069-1075.
16. Hoshino, K., Kashiwamura, K., Kuribayashi, K., Kodama, T., Tsujimura, T., Nakanishi, K., Matsuyama, T. et al., The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 1999. 190: 1541-1547.
17. Filisetti, A. and Candolfi, E., Immune response to Toxoplasma gondii. Ann. Ist. Super. Sanita 2004. 40: 71-80.
18. Jung, A. C. and Paauw, D. S., Diagnosing HIV-related disease. J. Gen. Intern. Med. 1998. 13: 131-136.
19. Andre, R., Lerouet, D., Kimber, I., Pinteaux, E. and Rothwell, N. J., Regulation of expression of the novel IL-1 receptor family members in the mouse brain. J. Neurochem. 2005. 95: 324-330.
20. Wilson, E. H and Hunter, C. A., The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis. Int. J. Parasitol. 2004. 34: 543-548.
21. Sibley, L. D., Adams, L. B., Fukutomi, Y. and Krahenbuhl, J. L., Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages. J. Immunol. 1991. 147: 2340-2345
22. Dziersczinski, F., Nishi, M., Ouko, L. and Roos, D. S., Dynamics of Toxoplasma gondii differentiation. Eukaryot. Cell 2004. 3: 992-1003.
23. Smith, J. E., A ubiquitous intracellular parasite: the cellular biology of Toxoplasma gondii. Int. J. Parasitol. 1995. 25: 1301-1309.
24. Blackwell, J. M., Roberts, C. W. and Alexander, J., Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasit. Immunol. 1993. 15: 317-325.
25. Denkers, E. Y., Butcher, B. A. and Bennouna, S., Neutrophils, dendritic cells and Toxoplasma. Int. J. Parasitol. 2004. 34: 411-421.
26. Denkers, E. Y., T lymphocyte dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect. 1999. 1: 699-708.
27. Denkers, E. Y. and Gazzinelli, R. T., Regulation and function of T-cell mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 1998. 11: 569-588.
28. Schlüter, D., Deckert-Schlüter, M., Lorenz, E., Meyer, T., Röllinghoff, M. and Bogdan, C., Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. J. Immunol. 1999. 162: 3512-3518.
29. Suzuki, Y., Kang, H., Parmley, S., Lim, S. and Park, D., Induction of tumor necrosis factor-α and inducible nitric oxide synthase fails to prevent toxoplasmic encephalitis in the absence of interferon-γ in genetically resistant BALB/c mice. Microbes Infect. 2000. 2: 455-462.
30. Licinio, J., Prolo, P., McCann, S. M. and Wong, M. L., Brain iNOS: current understanding and clinical implications. Mol. Med. Today 1999. 5: 225-232.
31. Muñoz-Fernández, M. A. and Fresno, M., The role of tumour-necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 1998. 56: 307-340.
32. Navikas, V. and Link, H., Review: Cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 1996. 45: 322-333.
33. Collazo, C. M., Yap, G. S., Hieny, S., Caspar, P., Feng, C. G, Taylor, G. A. and Sher, A., The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is STAT1 dependent and requires expression in both haematopoietic and nonhaematopoietic cellular compartments. Infect. Immun. 2002. 70: 6933-6939.
34. Norose, K., Mun, H. S., Aosai, F., Chen, M., Hata, H., Tagawa, Y., Iwakura, Y. and Yano, A., Organ infectivity of Toxoplasma gondii in interferon-γ knockout mice. J. Parasitol. 2001. 87: 452-454.
35. Scharton-Kersten, T., Wynn, T. A., Denkers, E. Y., Bala, S., Grunvald, E., Hieny, S., Gazzinelli, R. T. and Sher, A., In the absence of endogenous IFN-γ mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 1996. 157: 4045-4054.
36. Suzuki, Y., Orellana, M. A., Schreiber, R. D. and Remington, J. S., Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988. 240: 516-518.
37. Suzuki, Y., Sher, A., Yap, G., Park, D., Neyer, L. E., Liesenfeld, O., Fort, M. et al., IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/ 6mice following peroral infection with Toxoplasma gondii. J. Immunol. 2000. 164: 5375-5382.
38. Wilson, E. H.,Wille-Reece, U., Dzierszinski, F. and Hunter, C. A., A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J. Neuroimmunol. 2005. 165: 63-74.
39. Roberts, C.W., Ferguson, D. J. P., Jebbari, H., Satoskar, A., Bluethmann, H. and Alexander, J., Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect. Immun. 1996. 64: 897-904.
40. Suzuki, Y., Yang, Q., Nguyen, N., Lim, S., Liesenfeld, O., Kojima, T. and Remington, J. S., IL-4 is protective against development of toxoplasmic encephalitis. J. Immunol. 1996. 157: 2564-2569.
41. Gazzinelli, R. T.,Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Khun, R., Muller, W. et al., In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 1996. 157: 798-805.
42. Wynn, T. A., IL-13 effector functions. Ann. Rev. Immunol. 2003. 21: 425-456.
43. Shin, W. H., Lee, D. Y., Park, K. W., Kim, S. U., Yang, M. S., Joe, E. H. and Jin, B.K., Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 2004. 46: 142-152.
44. Drögemüller, K., Helmuth, U., Brunn, A., Sakowicz-Burkiewicz, M., Gutmann, D. H., Mueller, W., Deckert, M. and Schlüter, D., Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J. Immunol. 2008. 181: 2683-2693.
45. Schlüter, D., Deckert, M., Hof, H. and Frei, K., Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumour necrosis factor- stimulated neurons fail to inhibit the invasion and growth of T.gondii. Infect. Immun. 2001. 69: 7889-7893.
46. Scheidegger, A., Vonlaufen, N., Naguleswaran, A., Gianinazzi, C., Muller, N., Leib, S. L. and Hemphill, A., Differential effects of interferon-gamma and tumor necrosis factor-alpha on Toxoplasma gondii proliferation in organotypic rat brain slice cultures. J. Parasitol. 2005. 91: 307-315.
47. Andrade, R. M., Portillo, J. A. C., Wessendarp, M. and Subauste, C. S., CD40 signalling in macrophages induces anti-microbial activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates. Infect. Immun. 2005. 73: 3115-3123.
48. Subauste, C. S and Wessendarp, M., CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon. Infect. Immun. 2006. 74: 1573-1579.
49. Reichmann, G., Walker, W., Villegas, E. N., Craig, L., Cai, G., Alexander, J. and Hunter, C. A., The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect. Immun. 2000. 68: 1312-1318.
50. Sayles, P. C., Gibson, G. W. and Johnson, L. L., B cells are essential for vaccination-induced resistance to virulent. Toxoplasma gondii. Infect. Immun. 2000. 68: 1026-1033
51. Giulietti, A., Overbergh, L., Valckx, D., Decallonne, B., Bouillon, R. and Mathieu, C., An overview of real-time quantitative PCR: applications to quantify gene expression. Methods 2001. 25: 386-401.
52. Livak, K. J. and Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001. 25: 402-408.